Late breaking abstracts – Orals
LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*

https://doi.org/10.1016/S0168-8278(15)30149-5Get rights and content

References (0)

Cited by (0)

View full text